These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 1475541

  • 1. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
    Fick RB, Sonoda F, Hornick DB.
    Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
    Kubesch P, Lingner M, Grothues D, Wehsling M, Tümmler B.
    Scand J Gastroenterol Suppl; 1988 Sep; 143():77-80. PubMed ID: 3133755
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G.
    APMIS Suppl; 1995 Sep; 50():1-30. PubMed ID: 7756034
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis.
    Sajjan U, Reisman J, Doig P, Irvin RT, Forstner G, Forstner J.
    J Clin Invest; 1992 Feb; 89(2):657-65. PubMed ID: 1737853
    [Abstract] [Full Text] [Related]

  • 10. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E, Taccetti G, Campana S, Turchini S, Marianelli L.
    Pediatr Med Chir; 2001 Feb; 23(1):27-30. PubMed ID: 11486418
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunology of Pseudomonas aeruginosa infection in cystic fibrosis.
    Høiby N, Pedersen SS, Jensen ET, Pressler T, Shand GH, Kharazmi A, Döring G.
    Acta Univ Carol Med (Praha); 1990 Feb; 36(1-4):16-21. PubMed ID: 2130683
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN, Ratjen F.
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [Abstract] [Full Text] [Related]

  • 17. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
    Meyer KC, Zimmerman J.
    J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
    [Abstract] [Full Text] [Related]

  • 18. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB.
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [Abstract] [Full Text] [Related]

  • 19. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
    Murray TS, Egan M, Kazmierczak BI.
    Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
    [Abstract] [Full Text] [Related]

  • 20. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
    Klepac-Ceraj V, Lemon KP, Martin TR, Allgaier M, Kembel SW, Knapp AA, Lory S, Brodie EL, Lynch SV, Bohannan BJ, Green JL, Maurer BA, Kolter R.
    Environ Microbiol; 2010 May; 12(5):1293-303. PubMed ID: 20192960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.